APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dog Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dog Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchDog Vaccines Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Dog Vaccines Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Dog Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dog Vaccines Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dog Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Dog Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dog Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dog Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dog Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dog Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dog Vaccines include Zoetis (Pfizer), Merck Animal Health, Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Heska Co. and Ceva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dog Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dog Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dog Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dog Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Dog Vaccines Segment by Company

Zoetis (Pfizer)

Merck Animal Health

Eli Lilly

Bayer Healthcare

Virbac

Vetoquinol S.A

Merial (Sanofi)

Heska Co.

Ceva

Boehringer Ingelheim

Dog Vaccines Segment by Type

Recombinant Vaccines

Subunit Vaccines

Inactivated Vaccines

Toxoid Vaccines

Attenuated Live Vaccines

Conjugate Vaccines

DNA Vaccines

Dog Vaccines Segment by Application

Below 6 Months

Above Months

Dog Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dog Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dog Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dog Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dog Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dog Vaccines Industry Trends Table 2. Dog Vaccines Industry Drivers Table 3. Dog Vaccines Industry Opportunities and Challenges Table 4. Dog Vaccines Industry Restraints Table 5. Global Dog Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dog Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dog Vaccines Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Dog Vaccines Sales Market Share by Manufacturers Table 9. Global Dog Vaccines Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Dog Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dog Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dog Vaccines Manufacturers, Product Type & Application Table 13. Global Dog Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dog Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Recombinant Vaccines Table 17. Major Manufacturers of Subunit Vaccines Table 18. Major Manufacturers of Inactivated Vaccines Table 19. Major Manufacturers of Toxoid Vaccines Table 20. Major Manufacturers of Attenuated Live Vaccines Table 21. Major Manufacturers of Conjugate Vaccines Table 22. Major Manufacturers of DNA Vaccines Table 23. Global Dog Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Dog Vaccines Sales by Type (2021-2026) & (k units) Table 25. Global Dog Vaccines Sales by Type (2027-2032) & (k units) Table 26. Global Dog Vaccines Sales Market Share by Type (2021-2026) Table 27. Global Dog Vaccines Sales Market Share by Type (2027-2032) Table 28. Global Dog Vaccines Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 29. Global Dog Vaccines Revenue by Type (2021-2026) & (k units) Table 30. Global Dog Vaccines Revenue by Type (2027-2032) & (k units) Table 31. Global Dog Vaccines Revenue Market Share by Type (2021-2026) Table 32. Global Dog Vaccines Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Below 6 Months Table 34. Major Manufacturers of Above Months Table 35. Global Dog Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Dog Vaccines Sales by Application (2021-2026) & (k units) Table 37. Global Dog Vaccines Sales by Application (2027-2032) & (k units) Table 38. Global Dog Vaccines Sales Market Share by Application (2021-2026) Table 39. Global Dog Vaccines Sales Market Share by Application (2027-2032) Table 40. Global Dog Vaccines Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Dog Vaccines Revenue by Application (2021-2026) & (k units) Table 42. Global Dog Vaccines Revenue by Application (2027-2032) & (k units) Table 43. Global Dog Vaccines Revenue Market Share by Application (2021-2026) Table 44. Global Dog Vaccines Revenue Market Share by Application (2027-2032) Table 45. Global Dog Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Dog Vaccines Sales by Region (2021-2026) & (k units) Table 47. Global Dog Vaccines Sales Market Share by Region (2021-2026) Table 48. Global Dog Vaccines Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Dog Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Dog Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Dog Vaccines Sales by Country (2021-2026) & (k units) Table 52. North America Dog Vaccines Sales by Country (2027-2032) & (k units) Table 53. Europe Dog Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Dog Vaccines Sales by Country (2021-2026) & (k units) Table 55. Europe Dog Vaccines Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Dog Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Dog Vaccines Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Dog Vaccines Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Dog Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Dog Vaccines Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Dog Vaccines Sales by Country (2027-2032) & (k units) Table 62. Global Dog Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Dog Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Dog Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Dog Vaccines Revenue Market Share by Region (2021-2026) Table 66. Global Dog Vaccines Revenue Market Share by Region (2027-2032) Table 67. Zoetis (Pfizer) Company Information Table 68. Zoetis (Pfizer) Business Overview Table 69. Zoetis (Pfizer) Dog Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Zoetis (Pfizer) Dog Vaccines Product Portfolio Table 71. Zoetis (Pfizer) Recent Development Table 72. Merck Animal Health Company Information Table 73. Merck Animal Health Business Overview Table 74. Merck Animal Health Dog Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck Animal Health Dog Vaccines Product Portfolio Table 76. Merck Animal Health Recent Development Table 77. Eli Lilly Company Information Table 78. Eli Lilly Business Overview Table 79. Eli Lilly Dog Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Eli Lilly Dog Vaccines Product Portfolio Table 81. Eli Lilly Recent Development Table 82. Bayer Healthcare Company Information Table 83. Bayer Healthcare Business Overview Table 84. Bayer Healthcare Dog Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Bayer Healthcare Dog Vaccines Product Portfolio Table 86. Bayer Healthcare Recent Development Table 87. Virbac Company Information Table 88. Virbac Business Overview Table 89. Virbac Dog Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Virbac Dog Vaccines Product Portfolio Table 91. Virbac Recent Development Table 92. Vetoquinol S.A Company Information Table 93. Vetoquinol S.A Business Overview Table 94. Vetoquinol S.A Dog Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Vetoquinol S.A Dog Vaccines Product Portfolio Table 96. Vetoquinol S.A Recent Development Table 97. Merial (Sanofi) Company Information Table 98. Merial (Sanofi) Business Overview Table 99. Merial (Sanofi) Dog Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Merial (Sanofi) Dog Vaccines Product Portfolio Table 101. Merial (Sanofi) Recent Development Table 102. Heska Co. Company Information Table 103. Heska Co. Business Overview Table 104. Heska Co. Dog Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Heska Co. Dog Vaccines Product Portfolio Table 106. Heska Co. Recent Development Table 107. Ceva Company Information Table 108. Ceva Business Overview Table 109. Ceva Dog Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Ceva Dog Vaccines Product Portfolio Table 111. Ceva Recent Development Table 112. Boehringer Ingelheim Company Information Table 113. Boehringer Ingelheim Business Overview Table 114. Boehringer Ingelheim Dog Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Boehringer Ingelheim Dog Vaccines Product Portfolio Table 116. Boehringer Ingelheim Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Dog Vaccines Distributors List Table 120. Dog Vaccines Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Dog Vaccines Product Image Figure 2. Global Dog Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dog Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Dog Vaccines Sales (2021-2032) & (k units) Figure 5. Global Dog Vaccines Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dog Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Recombinant Vaccines Image Figure 9. Subunit Vaccines Image Figure 10. Inactivated Vaccines Image Figure 11. Toxoid Vaccines Image Figure 12. Attenuated Live Vaccines Image Figure 13. Conjugate Vaccines Image Figure 14. DNA Vaccines Image Figure 15. Global Dog Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Dog Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Dog Vaccines Sales Market Share by Type (2021-2032) Figure 18. Global Dog Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Dog Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Dog Vaccines Revenue Market Share by Type (2021-2032) Figure 21. Below 6 Months Image Figure 22. Above Months Image Figure 23. Global Dog Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Dog Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Dog Vaccines Sales Market Share by Application (2021-2032) Figure 26. Global Dog Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Dog Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Dog Vaccines Revenue Market Share by Application (2021-2032) Figure 29. North America Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Dog Vaccines Sales Market Share by Country (2021-2032) Figure 31. U.S. Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Dog Vaccines Sales Market Share by Country (2021-2032) Figure 36. Germany Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Dog Vaccines Sales Market Share by Country (2021-2032) Figure 43. China Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Dog Vaccines Sales Market Share by Country (2021-2032) Figure 51. Brazil Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Dog Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Dog Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Dog Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Dog Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. North America Dog Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Dog Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. Europe Dog Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Dog Vaccines Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Dog Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Dog Vaccines Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Dog Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Dog Vaccines Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Dog Vaccines Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Subunit Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • DNA Vaccines
Applications
  • Below 6 Months
  • Above Months
Companies covered
  • Zoetis (Pfizer)
  • Merck Animal Health
  • Eli Lilly
  • Bayer Healthcare
  • Virbac
  • Vetoquinol S.A
  • Merial (Sanofi)
  • Heska Co.
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dog Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dog Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dog Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dog Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dog Vaccines Market Dynamics
  1. 2.1 Dog Vaccines Industry Trends
  2. 2.2 Dog Vaccines Industry Drivers
  3. 2.3 Dog Vaccines Industry Opportunities and Challenges
  4. 2.4 Dog Vaccines Industry Restraints
3 Dog Vaccines Market by Manufacturers
  1. 3.1 Global Dog Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dog Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dog Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dog Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dog Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dog Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Dog Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dog Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dog Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dog Vaccines Tier 1, Tier 2, and Tier 3
4 Dog Vaccines Market by Type
  1. 4.1 Dog Vaccines Type Introduction
  2. 4.1.1 Recombinant Vaccines
  3. 4.1.2 Subunit Vaccines
  4. 4.1.3 Inactivated Vaccines
  5. 4.1.4 Toxoid Vaccines
  6. 4.1.5 Attenuated Live Vaccines
  7. 4.1.6 Conjugate Vaccines
  8. 4.1.7 DNA Vaccines
  9. 4.2 Global Dog Vaccines Sales by Type
  10. 4.2.1 Global Dog Vaccines Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Dog Vaccines Sales by Type (2021-2032)
  12. 4.2.3 Global Dog Vaccines Sales Market Share by Type (2021-2032)
  13. 4.3 Global Dog Vaccines Revenue by Type
  14. 4.3.1 Global Dog Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Dog Vaccines Revenue by Type (2021-2032)
  16. 4.3.3 Global Dog Vaccines Revenue Market Share by Type (2021-2032)
5 Dog Vaccines Market by Application
  1. 5.1 Dog Vaccines Application Introduction
  2. 5.1.1 Below 6 Months
  3. 5.1.2 Above Months
  4. 5.2 Global Dog Vaccines Sales by Application
  5. 5.2.1 Global Dog Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Dog Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Dog Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Dog Vaccines Revenue by Application
  9. 5.3.1 Global Dog Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Dog Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Dog Vaccines Revenue Market Share by Application (2021-2032)
6 Global Dog Vaccines Sales by Region
  1. 6.1 Global Dog Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dog Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Dog Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Dog Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dog Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dog Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dog Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dog Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dog Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dog Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dog Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dog Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dog Vaccines Revenue by Region
  1. 7.1 Global Dog Vaccines Revenue by Region
  2. 7.1.1 Global Dog Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dog Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Dog Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Dog Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dog Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Dog Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dog Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Dog Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dog Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dog Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dog Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dog Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis (Pfizer)
  2. 8.1.1 Zoetis (Pfizer) Company Information
  3. 8.1.2 Zoetis (Pfizer) Business Overview
  4. 8.1.3 Zoetis (Pfizer) Dog Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis (Pfizer) Dog Vaccines Product Portfolio
  6. 8.1.5 Zoetis (Pfizer) Recent Developments
  7. 8.2 Merck Animal Health
  8. 8.2.1 Merck Animal Health Company Information
  9. 8.2.2 Merck Animal Health Business Overview
  10. 8.2.3 Merck Animal Health Dog Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Animal Health Dog Vaccines Product Portfolio
  12. 8.2.5 Merck Animal Health Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly Dog Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly Dog Vaccines Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 Bayer Healthcare
  20. 8.4.1 Bayer Healthcare Company Information
  21. 8.4.2 Bayer Healthcare Business Overview
  22. 8.4.3 Bayer Healthcare Dog Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Healthcare Dog Vaccines Product Portfolio
  24. 8.4.5 Bayer Healthcare Recent Developments
  25. 8.5 Virbac
  26. 8.5.1 Virbac Company Information
  27. 8.5.2 Virbac Business Overview
  28. 8.5.3 Virbac Dog Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Virbac Dog Vaccines Product Portfolio
  30. 8.5.5 Virbac Recent Developments
  31. 8.6 Vetoquinol S.A
  32. 8.6.1 Vetoquinol S.A Company Information
  33. 8.6.2 Vetoquinol S.A Business Overview
  34. 8.6.3 Vetoquinol S.A Dog Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Vetoquinol S.A Dog Vaccines Product Portfolio
  36. 8.6.5 Vetoquinol S.A Recent Developments
  37. 8.7 Merial (Sanofi)
  38. 8.7.1 Merial (Sanofi) Company Information
  39. 8.7.2 Merial (Sanofi) Business Overview
  40. 8.7.3 Merial (Sanofi) Dog Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merial (Sanofi) Dog Vaccines Product Portfolio
  42. 8.7.5 Merial (Sanofi) Recent Developments
  43. 8.8 Heska Co.
  44. 8.8.1 Heska Co. Company Information
  45. 8.8.2 Heska Co. Business Overview
  46. 8.8.3 Heska Co. Dog Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Heska Co. Dog Vaccines Product Portfolio
  48. 8.8.5 Heska Co. Recent Developments
  49. 8.9 Ceva
  50. 8.9.1 Ceva Company Information
  51. 8.9.2 Ceva Business Overview
  52. 8.9.3 Ceva Dog Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ceva Dog Vaccines Product Portfolio
  54. 8.9.5 Ceva Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Dog Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Dog Vaccines Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dog Vaccines Value Chain Analysis
  2. 9.1.1 Dog Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dog Vaccines Production Mode & Process
  6. 9.2 Dog Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dog Vaccines Distributors
  9. 9.2.3 Dog Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst